No Data
Express News | BioLineRx Announces USPTO Allowance Of New Composition Of Matter Patent Covering Composition Of Motixafortide
12 Health Care Stocks Moving In Friday's After-Market Session
BioLineRx Launches 'Mobilization Matters': A Digital Resource for People With Multiple Myeloma Preparing for Stem Cell Collection
BioLine RX Initiated at Buy by Jones Trading
JonesTrading Initiates BioLine Rx(BLRX.US) With Buy Rating, Announces Target Price $2
Buy Rating Affirmed for Bioline RX Ltd on FDA Approval and Market Expansion Potential
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Add a quick analysis (30+ words) to join the 30,000 point pool! More entries (up to 10) = more points! Bonus: Share P/L for an extra 200 points!
.